WHO, the Global Fund, and medical malpractice in malaria treatment (Q35636073)

9 August 2017

1 reference

title

WHO, the Global Fund, and medical malpractice in malaria treatment (English)

1 reference

World Health Organization

9 August 2017

0 references

malaria

0 references

author

Sornchai Looareesuwan

8

object named as

Sornchai Looareesuwan

1 reference

9 August 2017

1

Amir Attaran

1 reference

9 August 2017

9

Michael Makanga

1 reference

9 August 2017

12

Jean François Trape

1 reference

9 August 2017

Karen I Barnes

2

1 reference

9 August 2017

Christopher Curtis

3

1 reference

9 August 2017

Umberto d'Alessandro

4

1 reference

9 August 2017

Caterina I Fanello

5

1 reference

9 August 2017

Mary R Galinski

6

1 reference

9 August 2017

Gilbert Kokwaro

7

1 reference

9 August 2017

Theonest K Mutabingwa

10

1 reference

9 August 2017

Ambrose Talisuna

11

1 reference

9 August 2017

William M Watkins

13

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

363

1 reference

9 August 2017

9404

1 reference

9 August 2017

237-240

1 reference

The "roll back malaria" campaign

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Impact of chloroquine resistance on malaria mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Artesunate combinations for treatment of malaria: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Averting a malaria disaster

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

History, dynamics, and public health importance of malaria parasite resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Malaria researchers say global fund is buying "useless drug".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

Increasing transparency in partnerships for health--introducing the Green Light Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

WHO links with consumers on reproductive health information

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915330-5

7 January 2021

10.1016/S0140-6736(03)15330-5

Identifiers

DOI

1 reference

9 August 2017

1 reference